TrialClinical rheumatology2024

Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.